Register entry

KITE PHARMA, INC.

Registered sites
5
Drug products
3
Live patents
0
Countries
2
Base
United States
Authorisation

Registered operations

What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.

Analytical testingActive ingredient (API) manufactureLabellingFinished drug manufacturePackaging
Sites

Facilities

5
SiteLocationOperationsFEI
Kite Pharma EU B.V.HoofddorpNetherlandsAnalytical testing, Labelling, Packaging3018906348
KITE PHARMA, INC.EL SEGUNDO, CAUnited StatesAnalytical testing, Labelling, Finished drug manufacture, Packaging3012583739
Kite Pharma, Inc.Frederick, MDUnited StatesAnalytical testing, Labelling, Finished drug manufacture, Packaging3016888173
Gilead Sciences, Inc.Oceanside, CAUnited StatesAnalytical testing, Active ingredient (API) manufacture3012871330
Kite Pharma, Inc.Santa Monica, CAUnited StatesAnalytical testing3014007584
Catalogue

Marketed products

3

Showing 3 of 3.

BrandGeneric nameFormCategory
TECARTUSbrexucabtagene autoleucelSUSPENSIONBLA
TECARTUSbrexucabtagene autoleucelSUSPENSIONBLA
YESCARTAaxicabtagene ciloleucelSUSPENSIONBLA
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.